These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25000468)
21. Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation. Isoda T; Mitsuiki N; Ohkawa T; Kaneko S; Endo A; Ono T; Aoki Y; Tomizawa D; Kajiwara M; Araki S; Nagasawa M; Morio T; Takagi M; Mizutani S J Pediatr Hematol Oncol; 2013 May; 35(4):e178-82. PubMed ID: 23242325 [TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma of the tongue in 5-year-old girl with dyskeratosis congenita. Jh K; Cs K Int J Oral Maxillofac Surg; 2021 Dec; 50(12):1546-1549. PubMed ID: 33736925 [TBL] [Abstract][Full Text] [Related]
23. Unrelated allogeneic hematopoietic stem cell transplantation in a patient with Revesz syndrome, a severe variant of dyskeratosis congenita. Watanabe K; Arakawa Y; Kambe T; Oguma E; Kishimoto H; Koh K Pediatr Blood Cancer; 2019 Jan; 66(1):e27476. PubMed ID: 30259646 [No Abstract] [Full Text] [Related]
24. A case of dyskeratosis congenita with portal hypertension associated with jugular venous anomaly. Yazgan Y; Demirtürk L; Ozel M; Başekim C Turk J Gastroenterol; 2006 Mar; 17(1):66-9. PubMed ID: 16830282 [TBL] [Abstract][Full Text] [Related]
25. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Ayas M; Nassar A; Hamidieh AA; Kharfan-Dabaja M; Othman TB; Elhaddad A; Seraihy A; Hussain F; Alimoghaddam K; Ladeb S; Fahmy O; Bazarbachi A; Mohamed SY; Bakr M; Korthof E; Aljurf M; Ghavamzadeh A Bone Marrow Transplant; 2013 Sep; 48(9):1168-72. PubMed ID: 23542225 [TBL] [Abstract][Full Text] [Related]
26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
27. Diffuse Mesangial Sclerosis in a Child With Dyskeratosis Congenita Leading to End-stage Renal Disease. Kamel A; Sayari T; Jellouli M; Hammi Y; Louzir RG; Gargah T Iran J Kidney Dis; 2016 Nov; 10(6):416-418. PubMed ID: 27904002 [TBL] [Abstract][Full Text] [Related]
28. Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan. Amarasinghe K; Dalley C; Dokal I; Laurie A; Gupta V; Marsh J Bone Marrow Transplant; 2007 Nov; 40(9):913-4. PubMed ID: 17724438 [No Abstract] [Full Text] [Related]
29. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Brazzola P; Duval M; Fournet JC; Gauvin F; Dalle JH; Champagne J; Champagne MA Bone Marrow Transplant; 2005 Dec; 36(12):1103-5; author reply 1105. PubMed ID: 16205731 [No Abstract] [Full Text] [Related]
30. Retinal hemorrhages in a patient with dyskeratosis congenita. Nazir S; Sayani N; Phillips PH J AAPOS; 2008 Aug; 12(4):415-7. PubMed ID: 18455938 [TBL] [Abstract][Full Text] [Related]
31. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature. Treister N; Lehmann LE; Cherrick I; Guinan EC; Woo SB Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):566-71. PubMed ID: 15529128 [TBL] [Abstract][Full Text] [Related]
32. Dyskeratosis congenita: its connections with oral and maxillofacial surgery. Sabesan T; Baheerathan NN; Ilankovan V Br J Oral Maxillofac Surg; 2007 Mar; 45(2):156-8. PubMed ID: 16024141 [TBL] [Abstract][Full Text] [Related]
33. Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita. Johnson CA; Hatfield M; Pulido JS Ophthalmic Genet; 2009 Dec; 30(4):181-4. PubMed ID: 19852575 [TBL] [Abstract][Full Text] [Related]
35. Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report. Zheng XY; Xu J; Li W; Li SS; Shi CP; Zhao ZY; Mao JH; Chen X Medicine (Baltimore); 2016 Mar; 95(12):e3106. PubMed ID: 27015183 [TBL] [Abstract][Full Text] [Related]
36. Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: A minireview. Ayas M Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):285-289. PubMed ID: 28644950 [TBL] [Abstract][Full Text] [Related]
37. [A case report of familial dyskeratosis congenital. Case report]. Luchkin AV; Mikhailova EA; Fidarova ZT; Troitskaya VV; Galtseva IV; Kovrigina AM; Glinkina SA; Dvirnyk VN; Raykina EV; Pavlova AV; Demina IA; Parovichnikova EN Ter Arkh; 2021 Jul; 93(7):818-825. PubMed ID: 36286734 [TBL] [Abstract][Full Text] [Related]
38. Dyskeratosis congenita: oral hyperkeratosis in association with lichenoid reaction. Handley TP; Ogden GR J Oral Pathol Med; 2006 Sep; 35(8):508-12. PubMed ID: 16918603 [TBL] [Abstract][Full Text] [Related]
39. Complications for a Hoyeraal-Hreidarsson Syndrome Patient with a Germline Chen RL; Lin KK; Chen LY Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269755 [TBL] [Abstract][Full Text] [Related]